EUVIMEDEUVIMED entdecken
Crossref

Microbial Bioprospecting and Antibacterial Potential of Natural Products Against Multidrug-Resistant Pathogens: A Review

T.S. Okanlawon,, M.A Olarinre, U.E. Tobby, A.M. Oluwasade, J.O. Ogunniran, J.O. Ogunrinade, A. O. Olayori, D.O. Oladeji, J.O. Oni, A.V. Adeyemi, A.V. Hamzat, C.E. Oladipo

BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE · 30.06.2026 · 10 (2) · 420-432

DOI: 10.64290/bima.v10i2.1622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE, online erschienen am 30.06.2026. Verfasst von T.S. Okanlawon, und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of multidrug-resistant (MDR) pathogens presents a significant challenge to public health, necessitating the exploration of alternative antimicrobial strategies. Microbial bioprospecting and natural products offer promising solutions, leveraging the diverse bioactive compounds produced by plants and microorganisms. This review examines the sources of antimicrobial microbes, including soil, water, insect microbiomes, and plant-associated endophytes, and highlights screening, isolation, and biochemical characterization techniques essential for identifying potent bioactive agents. Plant-derived compounds such as Allium sativum, Leucaena leucocephala, Ocimum gratissimum, and Sida acuta exhibit antimicrobial activity mediated by alkaloids, flavonoids, tannins, and essential oils, while microbial metabolites provide enzyme-mediated secondary metabolites with broad-spectrum effects. In vitro assays, including agar well and disc diffusion methods, as well as MIC and MBC determinations, alongside in silico approaches, facilitate the evaluation of antimicrobial potential. Applications span pharmaceutical, clinical, food safety, and environmental contexts, with significant biotechnological implications. Challenges include variability in compound production, extraction and purification difficulties, and the need for in vivo validation. Future directions emphasize the integration of genomics, metabolomics, and synthetic biology to enhance bioactive compound discovery. Therefore, microbial bioprospecting and natural products represent viable strategies for developing novel antimicrobials to combat MDR pathogens and improve public health outcomes.

Zitieren

APA

Okanlawon,, T., Olarinre, M., Tobby, U., Oluwasade, A., Ogunniran, J., Ogunrinade, J., Olayori, A. O., Oladeji, D., Oni, J., Adeyemi, A., Hamzat, A., & Oladipo, C. (2026). Microbial Bioprospecting and Antibacterial Potential of Natural Products Against Multidrug-Resistant Pathogens: A Review. BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE, 10(2), 420-432. https://doi.org/10.64290/bima.v10i2.1622

Vancouver

Okanlawon, T, Olarinre M, Tobby U, Oluwasade A, Ogunniran J, Ogunrinade J, et al. Microbial Bioprospecting and Antibacterial Potential of Natural Products Against Multidrug-Resistant Pathogens: A Review. BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE. 2026;10(2):420-432. doi:10.64290/bima.v10i2.1622

BibTeX
@article{Okanlawon2026,
  author = {Okanlawon,, T.S. and Olarinre, M.A and Tobby, U.E. and Oluwasade, A.M. and Ogunniran, J.O. and Ogunrinade, J.O. and Olayori, A. O. and Oladeji, D.O. and Oni, J.O. and Adeyemi, A.V. and Hamzat, A.V. and Oladipo, C.E.},
  title = {Microbial Bioprospecting and Antibacterial Potential of Natural Products Against Multidrug-Resistant Pathogens: A Review},
  journal = {BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {420--432},
  doi = {10.64290/bima.v10i2.1622}
}
Kostenlos starten →